tiprankstipranks
Tetralogic Pharma (TLOG)
OTHER OTC:TLOG
US Market

Tetralogic Pharma (TLOG) Income Statement

21 Followers

Tetralogic Pharma Income Statement

Last quarter (Q ), Tetralogic Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, Tetralogic Pharma's net income was $-8.63M. See Tetralogic Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 15Dec 14Dec 13Dec 12Dec 11
Total Revenue
-$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Cost of Revenue
-$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
-$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expense
$ 23.62M$ 38.50M$ 31.21M$ 17.99M$ 16.17M$ 18.87M
Operating Income
$ -23.62M$ -38.50M$ -31.21M$ -17.99M$ -16.17M$ -18.87M
Net Non Operating Interest Income Expense
$ -6.75M$ -6.28M$ -3.25M$ -2.77M$ -70.66K$ -1.85K
Other Income Expense
$ -12.67M$ -4.94M$ -1.50M$ 807.29K$ 43.14K$ -48.45K
Pretax Income
$ -43.04M$ -49.72M$ -35.96M$ -19.95M$ -16.20M$ -18.92M
Tax Provision
$ -2.32M-----
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -40.72M$ -49.72M$ -35.96M$ -23.20M$ -19.65M$ -22.19M
Basic EPS
$ -1.65$ -2.10$ -1.61$ -10.11$ -1.52$ -17.36
Diluted EPS
$ -1.65$ -2.10$ -1.63$ -10.11$ -1.52$ -17.36
Basic Average Shares
$ 99.09M$ 23.69M$ 22.29M$ 2.30M$ 10.63M$ 1.28M
Diluted Average Shares
$ 99.12M$ 23.73M$ 22.35M$ 2.30M$ 10.63M$ 1.28M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 23.62M$ 38.50M$ 31.21M$ 17.99M$ 16.17M$ 18.87M
Net Income From Continuing And Discontinued Operation
$ -40.72M$ -49.72M$ -35.96M$ -19.95M$ -16.20M$ -18.92M
Normalized Income
$ -27.86M$ -44.78M$ -34.46M$ -20.76M$ -16.24M$ -18.87M
Interest Expense
$ 6.80M$ 6.38M$ 3.36M$ 2.77M$ 73.35K$ 6.75K
EBIT
$ -36.24M$ -43.34M$ -32.60M$ -17.18M$ -16.13M$ -18.91M
EBITDA
$ -36.09M$ -43.15M$ -32.47M$ -17.08M$ -15.97M$ -18.70M
Currency in USD

Tetralogic Pharma Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis